PIK3CA and breast cancer: PIK3CA mutational analysis was performed among a sample of Iranian BC patients which showed lower frequency of mutation in high‐grade and advanced stage tumors (Ousati Ashtiani, Mehrsai, Pourmand, & Pourmand, 2018).